ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 129 filers reported holding ARATANA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $138,000 | +43.8% | 26,800 | 0.0% | 0.01% | +60.0% |
Q1 2019 | $96,000 | -61.8% | 26,800 | -34.6% | 0.01% | -64.3% |
Q4 2018 | $251,000 | -35.1% | 41,000 | -38.1% | 0.01% | -12.5% |
Q3 2018 | $387,000 | +44.9% | 66,218 | +5.6% | 0.02% | +60.0% |
Q2 2018 | $267,000 | -49.1% | 62,729 | -47.3% | 0.01% | -44.4% |
Q1 2018 | $525,000 | -16.1% | 119,100 | 0.0% | 0.02% | 0.0% |
Q4 2017 | $626,000 | -20.1% | 119,100 | -6.8% | 0.02% | -30.8% |
Q3 2017 | $783,000 | -15.8% | 127,800 | -0.6% | 0.03% | -29.7% |
Q2 2017 | $930,000 | +212.1% | 128,633 | +209.5% | 0.04% | +85.0% |
Q4 2016 | $298,000 | -63.1% | 41,563 | -51.9% | 0.02% | -57.4% |
Q3 2016 | $808,000 | +48.0% | 86,338 | 0.0% | 0.05% | +9.3% |
Q2 2016 | $546,000 | +112.5% | 86,338 | +85.5% | 0.04% | +168.8% |
Q1 2016 | $257,000 | +1.6% | 46,538 | +2.6% | 0.02% | -54.3% |
Q4 2015 | $253,000 | -38.3% | 45,338 | +10.9% | 0.04% | +218.2% |
Q3 2014 | $410,000 | – | 40,867 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
March Altus Capital Management LP | 218,515 | $2,045,000 | 12.79% |
Broadfin Capital, LLC | 3,085,979 | $28,885,000 | 2.59% |
First Light Asset Management, LLC | 467,743 | $4,378,000 | 1.88% |
AWM Investment Company, Inc. | 1,005,000 | $9,407,000 | 1.72% |
MPM ASSET MANAGEMENT LLC | 250,000 | $2,340,000 | 0.77% |
Grandeur Peak Global Advisors, LLC | 394,450 | $3,692,000 | 0.72% |
TURNER INVESTMENTS LLC | 208,660 | $1,953,000 | 0.65% |
WALL STREET ASSOCIATES | 197,400 | $1,848,000 | 0.63% |
TFS CAPITAL LLC | 192,848 | $1,805,000 | 0.43% |
GENERAL AMERICAN INVESTORS CO INC | 412,101 | $3,857,000 | 0.39% |